A	O
Rational	O
Engineering	B:C0035171
Strategy	I:C0035171
for	O
Designing	O
Protein	B:C0033618
A	I:C0033618
-	I:C0033618
Binding	I:C0033618
Camelid	B:C0325202
Single	B:C3494231
-	I:C3494231
Domain	I:C3494231
Antibodies	I:C3494231
.	O

Staphylococcal	B:C0038164
protein	I:C0038164
A	I:C0038164
(	O
Staphylococcal	B:C0038164
protein	I:C0038164
A	I:C0038164
)	O
and	O
streptococcal	B:C0075289
protein	I:C0075289
G	I:C0075289
(	O
streptococcal	B:C0075289
protein	I:C0075289
G	I:C0075289
)	O
affinity	B:C0008551
chromatography	I:C0008551
are	O
the	O
gold	O
standards	O
for	O
purifying	O
monoclonal	B:C0003250
antibodies	I:C0003250
(	O
monoclonal	B:C0003250
antibodies	I:C0003250
)	O
in	O
therapeutic	B:C0278296
applications	I:C0278296
.	O

However	O
,	O
camelid	B:C0325202
VHH	B:C3494234
single	I:C3494234
-	I:C3494234
domain	I:C3494234
Abs	I:C3494234
(	O
sdAbs	B:C3494231
or	O
VHHs	B:C3494234
)	O
are	O
not	O
bound	O
by	O
streptococcal	B:C0075289
protein	I:C0075289
G	I:C0075289
and	O
only	O
sporadically	O
bound	O
by	O
Staphylococcal	B:C0038164
protein	I:C0038164
A.	I:C0038164
Currently	O
,	O
VHHs	B:C3494234
require	O
affinity	O
tag	B:C0597301
-	I:C0597301
based	I:C0597301
purification	I:C0597301
,	O
which	O
limits	O
their	O
therapeutic	O
potential	O
and	O
adds	O
considerable	O
complexity	B:C1292781
and	O
cost	O
to	O
their	O
production	O
.	O

Here	O
we	O
describe	O
a	O
simple	O
and	O
rapid	O
mutagenesis	B:C3146302
-	O
based	O
approach	O
designed	O
to	O
confer	O
Staphylococcal	B:C0038164
protein	I:C0038164
A	I:C0038164
binding	B:C0033618
upon	O
a	O
priori	O
non-SpA-	B:C3494234
binding	I:C3494234
VHHs	I:C3494234
.	O

We	O
show	O
that	O
Staphylococcal	B:C0038164
protein	I:C0038164
A	I:C0038164
binding	B:C0033618
of	O
VHHs	B:C3494234
is	O
determined	O
primarily	O
by	O
the	O
same	O
set	O
of	O
residues	O
as	O
in	O
human	B:C0086418
monoclonal	B:C0003250
antibodies	I:C0003250
,	O
albeit	O
with	O
an	O
unexpected	O
degree	O
of	O
tolerance	O
to	O
substitutions	B:C0525038
at	O
certain	O
core	O
and	O
non-core	O
positions	O
and	O
some	O
limited	O
dependence	O
on	O
at	O
least	O
one	O
residue	O
outside	O
the	O
Staphylococcal	B:C0038164
protein	I:C0038164
A	I:C0038164
interface	O
,	O
and	O
that	O
Staphylococcal	B:C0038164
protein	I:C0038164
A	I:C0038164
binding	B:C0033618
could	O
be	O
successfully	O
introduced	O
into	O
five	O
VHHs	B:C3494234
against	O
three	O
different	O
targets	O
with	O
no	B:C1513916
adverse	I:C1513916
effects	I:C1513916
on	O
expression	B:C1171362
yield	O
or	O
antigen	B:C1148575
binding	I:C1148575
.	O

Next	B:C2936622
-	I:C2936622
generation	I:C2936622
sequencing	I:C2936622
of	O
llama	B:C0023919
,	O
alpaca	B:C0002186
and	O
dromedary	B:C0013127
VHH	B:C1516006
repertoires	I:C1516006
suggested	O
that	O
species	O
differences	O
in	O
Staphylococcal	B:C0038164
protein	I:C0038164
A	I:C0038164
binding	B:C0033618
may	O
result	O
from	O
frequency	O
variation	O
in	O
specific	O
deleterious	O
polymorphisms	B:C0032529
,	O
especially	O
Ile57	O
.	O

Thus	O
,	O
the	O
Staphylococcal	B:C0038164
protein	I:C0038164
A	I:C0038164
binding	B:C0033618
phenotype	O
of	O
camelid	B:C0325202
VHHs	B:C3494234
can	O
be	O
easily	O
modulated	B:C0443264
to	O
take	O
advantage	O
of	O
tag	B:C0597301
-	I:C0597301
less	I:C0597301
purification	I:C0597301
techniques	O
,	O
although	O
the	O
frequency	O
with	O
which	O
this	O
is	O
required	O
may	O
depend	O
on	O
the	O
source	B:C0449424
species	I:C0449424
.	O

